Raymond James Financial reiterated their hold rating on shares of Cardiovascular Systems (NASDAQ:CSII) in a report published on Monday.

A number of other analysts have also recently commented on the stock. Zacks Investment Research upgraded shares of Cardiovascular Systems from a sell rating to a hold rating in a research report on Monday, November 13th. Needham & Company LLC restated a buy rating and issued a $36.00 price objective (down previously from $37.00) on shares of Cardiovascular Systems in a research report on Thursday, October 26th. Citigroup assumed coverage on shares of Cardiovascular Systems in a research report on Thursday, September 21st. They issued a market perform rating for the company. Finally, BidaskClub cut shares of Cardiovascular Systems from a sell rating to a strong sell rating in a research report on Friday, August 18th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $38.00.

Cardiovascular Systems (CSII) opened at $24.45 on Monday. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.30 and a quick ratio of 3.83. The firm has a market capitalization of $811.07, a price-to-earnings ratio of 1,188.50 and a beta of 2.52. Cardiovascular Systems has a 12 month low of $23.00 and a 12 month high of $33.11.

Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, October 25th. The medical device company reported ($0.06) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The company had revenue of $49.70 million for the quarter, compared to the consensus estimate of $51.00 million. During the same quarter in the prior year, the business posted ($0.06) EPS. The firm’s quarterly revenue was down .2% on a year-over-year basis. sell-side analysts forecast that Cardiovascular Systems will post -0.05 earnings per share for the current year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Advisor Group Inc. increased its holdings in Cardiovascular Systems by 0.4% during the 2nd quarter. Advisor Group Inc. now owns 8,165 shares of the medical device company’s stock worth $263,000 after purchasing an additional 35 shares in the last quarter. California Public Employees Retirement System increased its holdings in Cardiovascular Systems by 0.6% during the 1st quarter. California Public Employees Retirement System now owns 31,900 shares of the medical device company’s stock worth $902,000 after purchasing an additional 200 shares in the last quarter. Legal & General Group Plc increased its holdings in Cardiovascular Systems by 2.9% during the 2nd quarter. Legal & General Group Plc now owns 7,763 shares of the medical device company’s stock worth $249,000 after purchasing an additional 216 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Cardiovascular Systems by 1.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 25,114 shares of the medical device company’s stock worth $809,000 after purchasing an additional 299 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in Cardiovascular Systems by 0.7% during the 2nd quarter. American Century Companies Inc. now owns 81,325 shares of the medical device company’s stock worth $2,621,000 after purchasing an additional 568 shares in the last quarter. Institutional investors and hedge funds own 75.05% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Cardiovascular Systems’ (CSII) “Hold” Rating Reaffirmed at Raymond James Financial” was posted by Daily Political and is the property of of Daily Political. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.dailypolitical.com/2017/12/07/cardiovascular-systems-csii-hold-rating-reaffirmed-at-raymond-james-financial.html.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Analyst Recommendations for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.